Dysregulated carbohydrate and lipid metabolism and risk of atrial fibrillation in advanced old age.


Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
27 03 2023
Historique:
received: 12 07 2022
accepted: 07 12 2022
medline: 9 8 2023
pubmed: 23 12 2022
entrez: 22 12 2022
Statut: epublish

Résumé

Obesity and dysmetabolism are major risk factors for atrial fibrillation (AF). Fasting and postload levels of glucose and non-esterified fatty acids (NEFAs) reflect different facets of metabolic regulation. We sought to study their respective contributions to AF risk concurrently. We assessed levels of fasting and postload glucose and NEFA in the Cardiovascular Health Study to identify associations with AF incidence and, secondarily, with ECG parameters of AF risk available at baseline. Linear and Cox regressions were performed. The study included 1876 participants (age 77.7±4.4). During the median follow-up of 11.4 years, 717 cases of incident AF occurred. After adjustment for potential confounders, postload glucose showed an association with incident AF (HR per SD increment of postload glucose=1.11, 95% CI 1.02 to 1.21, p=0.017). Both glucose measures, but not NEFA, were positively associated with higher P wave terminal force in V1 (PTFV1); the association remained significant only for postload glucose when the two measures were entered together (β per SD increment=138 μV·ms, 95% CI 15 to 260, p=0.028). Exploratory analyses showed significant interaction by sex for fasting NEFA (p Among older adults, postload glucose was positively associated with incident AF, with consistent findings for PTFV1. In exploratory analyses, the relationship with AF appeared specific to women. These findings require further study but suggest that interventions to address postprandial dysglycaemia late in life might reduce AF.

Identifiants

pubmed: 36549682
pii: heartjnl-2022-321633
doi: 10.1136/heartjnl-2022-321633
pmc: PMC10285028
mid: NIHMS1862916
doi:

Substances chimiques

Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

606-611

Subventions

Organisme : NHLBI NIH HHS
ID : U01 HL080295
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL130114
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268200800007C
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC55222
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85086
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG053325
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85083
Pays : United States
Organisme : NHLBI NIH HHS
ID : K24 HL135413
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85080
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85081
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201200036C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800001C
Pays : United States
Organisme : NHLBI NIH HHS
ID : 75N92021D00006
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85082
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85079
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG023629
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: JRK reports stock ownership in Abbott, Bristol-Myers Squibb, Johnson & Johnson, Medtronic, Merck and Pfizer.

Auteurs

Cara N Pellegrini (CN)

Medical Service, San Francisco VA Health Care System, San Francisco, CA, USA cara.pellegrini@ucsf.edu.
Medicine, University of California, San Francisco, San Francisco, CA, USA.

Petra Buzkova (P)

Biostatics, University of Washington, Seattle, Washington, USA.

Adam Oesterle (A)

Medical Service, San Francisco VA Health Care System, San Francisco, CA, USA.
Medicine, University of California, San Francisco, San Francisco, CA, USA.

Susan R Heckbert (SR)

Epidemiology, University of Washington, Seattle, WA, USA.

Russell P Tracy (RP)

Pathology and Biochemistry, University of Vermont, Burlington, Vermont, USA.

David S Siscovick (DS)

Medicine and Epidemiology, New York Academy of Medicine, New York, New York, USA.

Kenneth J Mukamal (KJ)

Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

Luc Djoussé (L)

Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Jorge R Kizer (JR)

Medical Service, San Francisco VA Health Care System, San Francisco, CA, USA.
Medicine, University of California, San Francisco, San Francisco, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH